Single dose pharmacokinetics of doxepin in healthy volunteers
- PMID: 7293791
- DOI: 10.1111/j.1600-0773.1980.tb01575.x
Single dose pharmacokinetics of doxepin in healthy volunteers
Abstract
The pharmacokinetics of orally administered doxepin (50 mg) was studied in 8 healthy volunteers. Doxepin (DOX) and desmethyldoxepin (DDOX) concentrations in serum (or plasma) and red blood cells (RBCs) were measured by radioimmunoassay. Peak serum concentrations of DOX were observed at 1-2 hours and they ranged between 59.1-107.4 nmol/1. DOX disappearance was biphasic with a mean distribution half-life of 2.0 hrs and elimination half-life of 17.9 hrs. The mean total apparent volume of distribution was 22.7 l/kg and plasma clearance 0.93 l/hr/kg. The estimated mean first-pass metabolism of DOX was 71% assuming complete absorption. Peak DDOX concentrations were observed at 1-6 hours and they ranged between 35.0-117.8 nmol/l. DDOX elimination was monophasic with a mean apparent half-life of 28.5 hours. Equilibrium dialysis gave a mean protein binding of 75.5% for DOX and 76.0% for DDOX. A highly time dependent and interindividually variable RBC/plasma concentration ratio was observed for both substances. Initially the plasma concentrations were 3-4 times higher than the respective RBC concentrations, but at later time points more DOX and DDOX could be found from the RBCs than from plasma. The major reason for this seemed to be a slower elimination of both drugs from the erythrocytes than from plasma.
Similar articles
-
Doxepin kinetics.Clin Pharmacol Ther. 1978 May;23(5):573-9. doi: 10.1002/cpt1978235573. Clin Pharmacol Ther. 1978. PMID: 639432
-
Protein binding of doxepin and desmethyldoxepin.Acta Pharmacol Toxicol (Copenh). 1982 Aug;51(2):159-64. doi: 10.1111/j.1600-0773.1982.tb01008.x. Acta Pharmacol Toxicol (Copenh). 1982. PMID: 7113722
-
Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):38-42. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 3988390
-
Clinical pharmacokinetics of prazosin.Clin Pharmacokinet. 1980 Jul-Aug;5(4):365-76. doi: 10.2165/00003088-198005040-00004. Clin Pharmacokinet. 1980. PMID: 6994981 Review.
-
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001. Clin Pharmacokinet. 1976. PMID: 13958 Review.
Cited by
-
Stereoselective pharmacokinetics of doxepin isomers.Eur J Clin Pharmacol. 1992;42(5):539-44. doi: 10.1007/BF00314865. Eur J Clin Pharmacol. 1992. PMID: 1607001
-
The pharmacologic management of insomnia in patients with HIV.J Clin Sleep Med. 2009 Jun 15;5(3):251-62. J Clin Sleep Med. 2009. PMID: 19960648 Free PMC article. Review.
-
The influence of cimetidine versus ranitidine on doxepin pharmacokinetics.Eur J Clin Pharmacol. 1987;32(2):159-64. doi: 10.1007/BF00542189. Eur J Clin Pharmacol. 1987. PMID: 3582480
-
Utilizing Physiologically Based Pharmacokinetic Models to Support Rational Medication in Chinese Elderly Population.Drug Des Devel Ther. 2025 Apr 22;19:3077-3101. doi: 10.2147/DDDT.S501143. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40297312 Free PMC article.
-
Pharmacokinetic optimisation of tricyclic antidepressant therapy.Clin Pharmacokinet. 1993 Apr;24(4):301-18. doi: 10.2165/00003088-199324040-00004. Clin Pharmacokinet. 1993. PMID: 8491058 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources